Template:Pico of the day
From Wiki Journal Club
Clinical question of the day
In patients 70 years or younger with chronic lymphocytic leukemia (CLL), how does the safety and efficacy of ibrutinib-rituximab compare to the chemoimmunotherapy regimen of fludarabine-cyclophosphamide-rituxmiab?